Feasibility and preliminary effectiveness of a transdiagnostic cognitive behavioral therapy treatment approach for alcohol misuse integrated within HIV care in Zambia
赞比亚艾滋病毒护理中针对酒精滥用的跨诊断认知行为疗法的可行性和初步有效性
基本信息
- 批准号:9755276
- 负责人:
- 金额:$ 24.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-05 至 2019-09-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAdherenceAdultAfricaAfrica South of the SaharaAlcohol abuseAlcohol consumptionAlcohol or Other Drugs useAlcoholsBehavior TherapyBiological MarkersCaringClinicClinicalClinical effectivenessCognitive TherapyComorbidityCountryDataDatabasesDevelopmentEffectivenessElementsEnrollmentEnvironmentEpidemicEpidemiologyEvidence based interventionEvidence based treatmentFemaleFocus GroupsFundingGlucuronidesGoalsHIVHealthHealth care facilityHealth systemHuman ResourcesHybridsIncomeIndividualInhalant dose formIntegrative TherapyInternationalInterventionInterviewManualsMeasuresMental HealthMethodsModelingNational Institute of Allergy and Infectious DiseaseOutcomeParticipantPatient Self-ReportPatientsPersonsPrevalenceProceduresProgram DevelopmentProspective cohortRandomizedReportingResearchResourcesSeveritiesStructureSymptomsTestingTherapeutic InterventionTimeTrainingUnited States National Institutes of HealthUrineViralViral Load resultZambiaalcohol abstinencealcohol abuse therapyalcohol comorbidityalcohol interventionalcohol misusealcohol use disorderantiretroviral therapybasebehavioral healthbrief alcohol interventionbrief interventioncohortcost effectivecost effectivenesseffective therapyevidence basefollow-uphazardous drinkingimplementation strategyimprovedinformantinnovationmalemortalitynovelprospectivereduced alcohol useresponsestandard of caresubstance misusetherapy adherencetherapy developmenttransmission processtreatment programuptakevirtual
项目摘要
Alcohol use is increasing in sub-Saharan Africa (SSA) where it commonly intersects with the HIV/AIDS
epidemic. Hazardous alcohol use increases HIV transmission, impedes uptake and retention on antiretroviral
therapy (ART), and ultimately reduces HIV viral suppression (VS). Approximately 20-50% of persons living with
HIV (PLWH) on ART drink hazardously; however, most clinics in SSA offer only brief interventions (BIs) for
alcohol reduction that are ineffective for many patients. BIs have limited ability to address more severe alcohol
use disorders (AUDs) or comorbid mental health or substance use issues (hereafter called `comorbidities') that
are common among PLWH. In preliminary studies, we found that 40% of male and 20% of female PLWH on
ART in Zambia had hazardous alcohol use, that ~60% failed to respond to current BIs, and that >50% had
comorbidities. We previously developed and demonstrated the effectiveness of a novel cognitive-behavioral
therapy intervention, Common Elements Treatment Approach (CETA), which trains lay health workers to
address both AUDs and comorbidities. Our central hypothesis is that a stepped care approach to alcohol use,
where interventions ranging in time and resource intensity are provided according to symptom severity, can be
utilized by HIV treatment programs in SSA to effectively and efficiently address hazardous alcohol use and
improve HIV outcomes. In this application, we propose a Stage 1 hybrid effectiveness-implementation study to
adapt and pilot test CETA at two Zambian HIV clinics for PLWH who report hazardous alcohol use and are less
likely to respond to BIs (i.e., those with moderate-to-severe alcohol use disorders (AUDs) and/or
comorbidities). This project leverages (a) our development of CETA, (b) a prospective cohort of HIV-infected
individuals that was created by the NIAID-funded International Epidemiological Databases to Evaluate AIDS,
and (c) >10 years of HIV and mental health research in Zambia. Aim 1 will adapt the current CETA manual for
HIV-infected individuals and HIV clinics with input from PLWH, health workers, and key informants in the health
system. In Aim 2, PLWH who screen positive for hazardous alcohol use will be enrolled and assessed for AUD
and comorbidities. Those with moderate-to-severe AUD and/or comorbidities (n=160) will be randomized 1:1 to
receive BI alone or BI+CETA. Participants with subthreshold/mild AUD and without comorbidities will also
receive the BI. Changes in alcohol use, comorbidities, and HIV outcomes (ART retention and HIV viral
suppression) will be measured over 6 months of follow-up and the impact of the interventions will be evaluated.
Urine Ethyl glucuronide testing will be used to augment self-reported alcohol measures. Aim 3 will investigate
feasibility, acceptability, and other implementation factors related to delivery of BI and CETA. This study will:
(1) result in an HIV-adapted CETA manual, (2) generate preliminary effectiveness and implementation data on
CETA and BI in PLWH drinkers with comorbidities, and (3) inform an R01 application to further test a stepped
care approach to address hazardous drinking in HIV care settings.
撒哈拉以南非洲 (SSA) 的饮酒量正在增加,那里的饮酒通常与艾滋病毒/艾滋病有关
流行性。有害饮酒会增加艾滋病毒传播,阻碍抗逆转录病毒药物的吸收和保留
治疗(ART),并最终减少 HIV 病毒抑制(VS)。大约 20-50% 的人生活在
艾滋病毒感染者(PLWH)饮用抗逆转录病毒疗法(ART)是危险的;然而,SSA 的大多数诊所只提供简短的干预 (BI)
减少饮酒对许多患者来说是无效的。 BI 解决更严重酒精问题的能力有限
使用障碍 (AUD) 或合并心理健康或物质使用问题(以下称为“合并症”)
在 PLWH 中很常见。在初步研究中,我们发现 40% 的男性和 20% 的女性感染者
赞比亚的 ART 存在危险的酒精使用,约 60% 未能对当前的 BI 做出反应,并且 > 50% 有
合并症。我们之前开发并证明了一种新颖的认知行为的有效性
therapy intervention, Common Elements Treatment Approach (CETA), which trains lay health workers to
解决 AUD 和合并症。我们的中心假设是对饮酒采取阶梯式护理方法,
where interventions ranging in time and resource intensity are provided according to symptom severity, can be
SSA 的艾滋病毒治疗计划利用该方案有效地解决有害酒精使用问题
改善艾滋病毒结果。在此应用中,我们提出了第一阶段混合有效性实施研究
adapt and pilot test CETA at two Zambian HIV clinics for PLWH who report hazardous alcohol use and are less
likely to respond to BIs (i.e., those with moderate-to-severe alcohol use disorders (AUDs) and/or
合并症)。该项目利用 (a) 我们开发的 CETA,(b) 艾滋病毒感染者的前瞻性队列
individuals that was created by the NIAID-funded International Epidemiological Databases to Evaluate AIDS,
and (c) >10 years of HIV and mental health research in Zambia. Aim 1 will adapt the current CETA manual for
HIV-infected individuals and HIV clinics with input from PLWH, health workers, and key informants in the health
系统。 In Aim 2, PLWH who screen positive for hazardous alcohol use will be enrolled and assessed for AUD
和合并症。 Those with moderate-to-severe AUD and/or comorbidities (n=160) will be randomized 1:1 to
receive BI alone or BI+CETA. Participants with subthreshold/mild AUD and without comorbidities will also
接收 BI。 Changes in alcohol use, comorbidities, and HIV outcomes (ART retention and HIV viral
suppression) will be measured over 6 months of follow-up and the impact of the interventions will be evaluated.
Urine Ethyl glucuronide testing will be used to augment self-reported alcohol measures.目标 3 将进行调查
可行性、可接受性以及与 BI 和 CETA 交付相关的其他实施因素。这项研究将:
(1) result in an HIV-adapted CETA manual, (2) generate preliminary effectiveness and implementation data on
CETA and BI in PLWH drinkers with comorbidities, and (3) inform an R01 application to further test a stepped
care approach to address hazardous drinking in HIV care settings.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy Calvin Kane其他文献
Jeremy Calvin Kane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy Calvin Kane', 18)}}的其他基金
Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkers
改进对撒哈拉以南非洲受艾滋病毒影响的青少年饮酒量的测量:生物标志物的评估和实施
- 批准号:
10616727 - 财政年份:2020
- 资助金额:
$ 24.13万 - 项目类别:
Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkers
改进对撒哈拉以南非洲受艾滋病毒影响的青少年饮酒量的测量:生物标志物的评估和实施
- 批准号:
10400760 - 财政年份:2020
- 资助金额:
$ 24.13万 - 项目类别:
Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkers
改进对撒哈拉以南非洲受艾滋病毒影响的青少年饮酒量的测量:生物标志物的评估和实施
- 批准号:
10158010 - 财政年份:2020
- 资助金额:
$ 24.13万 - 项目类别:
FEASIBILITY AND PRELIMINARY EFFECTIVENESS OF A TRANSDIAGNOSTIC COGNITIVE BEHAVIORAL THERAPY TREATMENT APPROACH FOR ALCOHOL MISUSE INTEGRATED WITHIN HIV CARE IN ZAMBIA
赞比亚将酒精滥用跨诊断认知行为疗法纳入艾滋病毒护理的可行性和初步有效性
- 批准号:
10121170 - 财政年份:2020
- 资助金额:
$ 24.13万 - 项目类别:
Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkers
改进对撒哈拉以南非洲受艾滋病毒影响的青少年饮酒量的测量:生物标志物的评估和实施
- 批准号:
9623507 - 财政年份:2020
- 资助金额:
$ 24.13万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 24.13万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 24.13万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 24.13万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 24.13万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 24.13万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 24.13万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 24.13万 - 项目类别: